Intervention Review

Immunosuppressive agents for myasthenia gravis

  1. Ian K Hart1,*,
  2. Sivakumar Sathasivam2,
  3. Tarek Sharshar3

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 17 OCT 2007

Assessed as up-to-date: 21 AUG 2007

DOI: 10.1002/14651858.CD005224.pub2


How to Cite

Hart IK, Sathasivam S, Sharshar T. Immunosuppressive agents for myasthenia gravis. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD005224. DOI: 10.1002/14651858.CD005224.pub2.

Author Information

  1. 1

    The Walton Centre for Neurology and Neurosurgery, University Division of Neuroscience, Liverpool, UK

  2. 2

    The Walton Centre for Neurology and Neurosurgery, Neurology Department, Liverpool, UK

  3. 3

    Hôpital Raymond Poincaré, Service de Réanimation Médicale, Garches, Ile de France, France

*Ian K Hart, University Division of Neuroscience, The Walton Centre for Neurology and Neurosurgery, Lower Lane, Liverpool, L9 7LJ, UK. i.k.hart@liverpool.ac.uk. ian@kirkhart.freeserve.co.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 OCT 2007

SEARCH

  1. Current Version

    Immunosuppressive agents for myasthenia gravis

    Ian K Hart, Sivakumar Sathasivam and Tarek Sharshar

    Article first published online: 17 OCT 2007 | DOI: 10.1002/14651858.CD005224.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Immunosuppressive agents for myasthenia gravis

    I Hart, S Sathasivam and T Sharshar

    Article first published online: 20 APR 2005 | DOI: 10.1002/14651858.CD005224